Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer

OBJECTIVES: To test for evidence of statin‐mediated effects in patients with castration‐resistant prostate cancer (CRPC) as post‐diagnosis use of statins in patients with prostate cancer is associated with favourable survival outcome. PATIENTS AND METHODS: The SPECTRE trial was a 6‐weeks‐long proof‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Rushworth, Linda K., Loveridge, Carolyn, Salji, Mark, MacLeod, Martin, Mui, Ernest, Sumpton, David, Neilson, Matthew, Hedley, Ann, Alexander, Laura, McCartney, Elaine, Patel, Rachana, Wallace, Jan, Delles, Christian, Jones, Rob, Leung, Hing Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087532/
https://www.ncbi.nlm.nih.gov/pubmed/35844167
http://dx.doi.org/10.1111/bju.15851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087532/
https://www.ncbi.nlm.nih.gov/pubmed/35844167
http://dx.doi.org/10.1111/bju.15851

Ejemplares similares